Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X

Events

Single-cell mutational profiling enhances the clinical evaluation of AML MRD

VIRTUAL
Zoom meeting
July 21, 2020

Early detection of Minimal Residual Disease (MRD) detection holds great promise for patient therapy selection. Ongoing clinical trials indicate mutations detected early on, offer better patient stratification and treatment options which may prevent relapse.

DATE & TIME
07.21.2020
9:30AM
LOCATION
Zoom meeting
PUBLICATION
NUMBER
PRESENTERS
Asiri Ediriwickrema, MD
SESSION
Dr. Asiri Ediriwickrema from the Majeti lab at Stanford University, will discuss his recent publication in Blood Advances and the promise of single-cell DNA sequencing technology for MRD detection in hematological malignancies.

REQUEST QUOTE